Who invested in CBT Pharmaceuticals?
CBT Pharmaceuticals's investors include OrbiMed Asia.
United States · Series A startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$9.8Mraised across 1 round since 2016, from 1 source
CBT Pharmaceuticals's investors include OrbiMed Asia.
CBT Pharmaceuticals has raised $9.8M across 1 round since 2016.
CBT Pharmaceuticals's most recent round was a Series A of $9.8M in Aug 2016.
Its most recent round, $9.8M in Aug 2016, is also its largest on record.
CBT Pharmaceuticals's first round on record, in Aug 2016, was backed by OrbiMed Asia.
CBT Pharmaceuticals's latest named round is a Series A, in Aug 2016.
CBT Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.